Active	Status	Sponsor type	Region	Phase	Filter
15 Active 2 Inactive 17 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wang, Qian
NCT05024214: Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors	Recruiting	1/2	170	RoW	Lenvatinib + Envafolimab, Sunitinib	3D Medicines (Sichuan) Co., Ltd.	Solid Tumors, Non-small Cell Lung Cancer, Renal Cell Carcinoma, Hepatocellular Carcinoma	12/24	12/24
NCT04448379: Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer	Recruiting	1	48	RoW	JMT101, Afatinib or Osimertinib	Shanghai JMT-Bio Inc., CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	Locally Advanced or Metastatic Non-Small Cell Lung Cancer	12/21	06/22
Yang, Shi m
No trials found